TeiaCare, a Milan-based provider of AI-powered monitoring for residential long-term care facilities, has raised €7M ($8.2M) in funding led by P101 SGR. The ANCELIA platform uses privacy-respecting optical sensors to track residents' conditions in real-time, sending notifications to caregivers and analytics to managers. The capital will accelerate product development, operations expansion, and entry into France and Spain.
Italian HealthTech VC Momentum Builds
The round comes amid surging investor interest in Italian healthtech, which attracted €600M in VC last year per P101. P101 led with €5M, joined by Spanish family offices Namarel and Inderhabs, signaling cross-border validation. Meanwhile, U.S. peers like Sensi.ai have raised over $100M, and SafelyYou secured a $43M Series C in 2025. TeiaCare differentiates with contactless optical AI tailored for European nursing homes (RSA), avoiding wearables' compliance issues.
Care Facility Overload Hits Crisis Levels
Italy's residential socio-healthcare facilities house 300,000 residents, with another 300,000 on waiting lists per La Repubblica. A 50,000-nurse shortage exacerbates night shifts, often one nurse per 100 patients. Rising costs and staffing gaps demand tech that augments human care without intrusion. Current solutions like wearables fail due to elderly non-compliance and privacy concerns.
Contactless Sensors Enable 24/7 Vigilance
ANCELIA deploys optical sensors for fall detection, wandering alerts, and activity monitoring, integrated with apps for caregivers and managers. Unlike CarePredict's $48M-funded wearables ($29M Series A-3 in 2023), TeiaCare's vision-based system requires no devices on residents, ensuring privacy and constant coverage. It balances workloads, prevents pressure ulcers, and provides data for personalized care.
Human-AI Synergy Redefines Night Shifts
The platform reduces unnecessary checks via virtual room access, freeing staff for meaningful interactions. Customers like ISRAA and Società Dolce report fall reductions and better family insights. As CEO Guido Magrin noted:
"Today, we have a unique opportunity to help define a new category of care solutions: practical tools that support care professionals, improve the quality of life for vulnerable individuals, and structurally address one of the major challenges of our time - population aging."
This approach aligns with EU ethical AI pushes.
P101 Backs Proven Italian Scale-Up
P101 SGR, with €500M AUM and 21 exits like Musixmatch, led as TeiaCare's 14th Programma 103 investment. Healthtech comprises 20% of their portfolio, fitting their thesis on AI-driven integrated care. Spanish investors Namarel and Inderhabs, active in residential care, add domain expertise for expansion.
Italy LTC Market Faces $13B Pressure
Italy's long-term care market stood at $13.3B in 2023, projected to reach $22.8B by 2030 at 8.2% CAGR per Grand View Research. AI in elderly care TAM hits $4-7B by 2026 per market reports. TeiaCare serves 50+ clients across 200+ facilities, covering 75,000 residents or 25% of Italy's RSA market.
PhD Tech Core Powers Differentiation
Co-founder Luca Iozzia's PhD on contactless cardio-respiratory monitoring via cameras directly informs ANCELIA's AI. CEO Guido Magrin, inspired by family care experience, pairs with serial founder Roberto Salamina (Ninacare). New CSO Alessio Frigeri brings Docebo scaling ops.
France-Spain Expansion Accelerates
Funds target France and Spain entry, home care extension, and advances in Data, Spatial, and Care Intelligence features. Partnerships like Zucchetti Healthcare bolster integrations. With 36 employees and recent hires in engineering and finance, TeiaCare eyes Europe-wide scaling amid aging demographics.